Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of Clinical Pharmacology"
DOI: 10.1002/jcph.1874
Abstract: Baricitinib is a JAK1/2 inhibitor that was first approved for treating moderate to severe rheumatoid arthritis (RA) but that later showed considerable efficacy in the control of exaggerated inflammatory responses that occur in a wide…
read more here.
Keywords:
baricitinib;
arthritis covid;
rheumatoid arthritis;
baricitinib rheumatoid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-217548
Abstract: We have read with great interest the recent article from Figueroa-Parra et al 1 entitled ‘Are my patients with rheumatic diseases at higher risk of COVID-19?’ We agree that patients with rheumatic diseases are at…
read more here.
Keywords:
management rheumatoid;
arthritis covid;
rheumatic diseases;
online management ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-241375
Abstract: A previously healthy 53-year-old man was hospitalised for 12 days due to COVID-19 with shortness of breath. A few days after discharge from hospital, the patient developed fever and severe pain in several joints in…
read more here.
Keywords:
reactive arthritis;
arthritis;
arthritis covid;
Sign Up to like & get
recommendations!
1
Published in 2020 at "RMD Open"
DOI: 10.1136/rmdopen-2020-001350
Abstract: Reactive arthritis (ReA) is typically preceded by sexually transmitted disease or gastrointestinal infection. An association has also been reported with bacterial and viral respiratory infections. Herein, we report the first case of ReA after the…
read more here.
Keywords:
arthritis covid;
reactive arthritis;
infection;
day ... See more keywords